A Phase I Study to Assess the Safety, Tolerability and Pharmacokinetic Profile of Boceprevir and Sildenafil When Dosed Separately and Together in Healthy Male Volunteers.
Phase of Trial: Phase I
Latest Information Update: 10 Dec 2016
At a glance
- Drugs Boceprevir (Primary) ; Sildenafil (Primary)
- Indications Erectile dysfunction; Hepatitis C; Pulmonary hypertension; Raynaud's disease
- Focus Pharmacokinetics
- 20 May 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 25 Jun 2013 Planned End Date changed from 14 Mar 2013 to 30 Apr 2013 as reported by United Kingdom Clinical Research Network.
- 25 Jun 2013 Status changed from recruiting to active, no longer recruiting as reported by United Kingdom Clinical Research Network.